Nvidia (NVDA, Financials) is drawing fresh bullish forecasts after a rapid five-year rally, with analysts now predicting the chipmaker could grow into a $5 trillion company. Warni ...

The stock attracted cornerstone investors including Hillhouse Investment, GIC and RBC Global Asset Management.

While HSBC maintains a 'buy' rating for Biocon it has cut its target price to Rs 390 from the earlier Rs 400 per share.